Combination effects of ellagic acid with erlotinib in a Ba/F3 cell line expressing EGFR H773_V774 insH mutation

BACKGROUND: Epidermal growth factor receptor H773_V774 insH (EGFR‐insH) is an EGFR exon 20 insertion mutation in non‐small cell lung cancer (NSCLC), which is naturally resistant to available EGFR tyrosine kinase inhibitors (TKIs) and lacks a patient‐derived cell line. METHODS: A Ba/F3 cell line expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Chuanqi, Kong, Jindong, Miao, Fujun, Wang, Xuanjun, Sheng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396384/
https://www.ncbi.nlm.nih.gov/pubmed/32525282
http://dx.doi.org/10.1111/1759-7714.13487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396384/
https://www.ncbi.nlm.nih.gov/pubmed/32525282
http://dx.doi.org/10.1111/1759-7714.13487

Ejemplares similares